Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2006 1
2008 2
2009 1
2010 1
2011 1
2012 5
2013 5
2014 5
2015 5
2016 2
2017 9
2018 7
2019 5
2020 7
2021 3
2022 8
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023.
Gligorov J, Benderra MA, Barthere X, de Forceville L, Antoine EC, Cottu PH, Delaloge S, Pierga JY, Belkacemi Y, Houvenaegel G, Pujol P, Rivera S, Spielmann M, Penault-Llorca F, Namer M; et l'ensemble des experts des votes des RPC Saint-Paul 2022-2023. Gligorov J, et al. Bull Cancer. 2023 Nov;110(10S):10S1-10S43. doi: 10.1016/S0007-4551(23)00473-3. Bull Cancer. 2023. PMID: 38061827
Fatigue visual analogue scale score correlates with quality of life in cancer patients receiving epoetin alfa (Sandoz) for chemotherapy-induced anaemia: The CIROCO study.
Desramé J, Baize N, Anota A, Laribi K, Stefani L, Hjiej S, Nabirotchkina E, Zelek L, Choquet S. Desramé J, et al. Among authors: zelek l. Cancer Treat Res Commun. 2023;37:100781. doi: 10.1016/j.ctarc.2023.100781. Epub 2023 Nov 23. Cancer Treat Res Commun. 2023. PMID: 38039763 Free article.
Dietary exposure to acrylamide and breast cancer risk: results from the NutriNet-Santé cohort.
Bellicha A, Wendeu-Foyet G, Coumoul X, Koual M, Pierre F, Guéraud F, Zelek L, Debras C, Srour B, Sellem L, Kesse-Guyot E, Julia C, Galan P, Hercberg S, Deschasaux-Tanguy M, Touvier M. Bellicha A, et al. Among authors: zelek l. Am J Clin Nutr. 2022 Oct 6;116(4):911-919. doi: 10.1093/ajcn/nqac167. Am J Clin Nutr. 2022. PMID: 36055962 Free article.
Influence of the SARS-CoV-2 outbreak on management and prognosis of new lung cancer cases, a retrospective multicentre real-life cohort study.
Priou S, Lamé G, Zalcman G, Wislez M, Bey R, Chatellier G, Cadranel J, Tannier X, Zelek L, Daniel C, Tournigand C, Kempf E; Assistance Publique – Hôpitaux de Paris (AP-HP) Cancer Group. Priou S, et al. Among authors: zelek l. Eur J Cancer. 2022 Sep;173:33-40. doi: 10.1016/j.ejca.2022.06.018. Epub 2022 Jun 27. Eur J Cancer. 2022. PMID: 35843177 Free PMC article.
[Cancer treatments].
Zelek L, Duchemann B. Zelek L, et al. Rev Prat. 2022 Jan;72(1):105-106. Rev Prat. 2022. PMID: 35258265 French. No abstract available.
Adoptive cell therapies in thoracic malignancies.
Lasvergnas J, Naigeon M, Chouahnia K, Zelek L, Chaput N, Duchemann B. Lasvergnas J, et al. Among authors: zelek l. Cancer Immunol Immunother. 2022 Sep;71(9):2077-2098. doi: 10.1007/s00262-022-03142-3. Epub 2022 Feb 7. Cancer Immunol Immunother. 2022. PMID: 35129636 Free PMC article. Review.
65 results